74
Participants
Start Date
July 31, 2009
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
AZD1152
1200 mg, iv, 7 day infusion
LDAC
20 mg, sc, bd, 10 days
Research Site, Atlanta
Research Site, Chicago
Research Site, New York
Research Site, Cleveland
Research Site, Portland
Research Site, Greenville
Research Site, Nashville
Research Site, Houston
Research Site, Westmead
Research Site, Herston
Research Site, Melbourne
Research Site, Parkville
Research Site, Angers
Research Site, Clermont-Ferrand
Research Site, Grenoble
Research Site, Lyon
Research Site, Marseille
Research Site, Nantes
Research Site, Duisburg
Research Site, Erlangen
Research Site, Frankfurt
Research Site, Münster
Research Site, Villingen-Schwenningen
Research Site, Bologna
Research Site, Genova
Research Site, Orbassano
Research Site, Udine
Research Site, Roma
Research Site, Nagoya
Research Site, Yoshida-gun
Research Site, Maebashi
Research Site, Isehara
Research Site, Yokohama
Research Site, Chūō
Research Site, Fukuoka
Research Site, Brasov
Research Site, TG Mures
Research Site, Badalona(barcelona)
Research Site, Barcelona
Research Site, Madrid
Research Site, Majadahonda
Research Site, Oviedo
Research Site, Valencia
Research Site, Brighton
Research Site, London
Lead Sponsor
AstraZeneca
INDUSTRY